Skip to Content

Putnam Research C PRACX

Medalist Rating as of | See Franklin Templeton Investment Hub
  • NAV / 1-Day Return 44.28  /  +0.07 %
  • Total Assets 533.0 Mil
  • Adj. Expense Ratio
    1.790%
  • Expense Ratio 1.790%
  • Distribution Fee Level Average
  • Share Class Type Level Load
  • Category Large Blend
  • Investment Style Large Blend
  • Min. Initial Investment
  • Status Open
  • TTM Yield
  • Turnover 35%

USD | NAV as of Mar 28, 2024 | 1-Day Return as of Mar 28, 2024, 10:16 PM GMT+0

Morningstar’s Analysis PRACX

Will PRACX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Putnam Research C boasts strong Process and People Pillar ratings, but other weaknesses hold this strategy's Morningstar Medalist Rating at Neutral.

null Morningstar Manager Research

Morningstar Manager Research

Summary

Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the most expensive quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings PRACX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 34.1
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Microsoft Corp

7.89 38.0 Mil
Technology

Apple Inc

4.57 22.0 Mil
Technology

Alphabet Inc Class A

4.11 19.8 Mil
Communication Services

Amazon.com Inc

3.97 19.1 Mil
Consumer Cyclical

NVIDIA Corp

2.98 14.3 Mil
Technology

Meta Platforms Inc Class A

2.29 11.0 Mil
Communication Services

Oracle Corp

2.25 10.8 Mil
Technology

Broadcom Inc

2.18 10.5 Mil
Technology

Advanced Micro Devices Inc

2.05 9.9 Mil
Technology

UnitedHealth Group Inc

1.84 8.9 Mil
Healthcare